Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Current Deferred Revenue (2016 - 2026)

Healthstream has reported Current Deferred Revenue over the past 16 years, most recently at $88.4 million for Q4 2025.

  • Quarterly Current Deferred Revenue rose 4.97% to $88.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $88.4 million through Dec 2025, up 4.97% year-over-year, with the annual reading at $88.4 million for FY2025, 4.97% up from the prior year.
  • Current Deferred Revenue was $88.4 million for Q4 2025 at Healthstream, up from $85.7 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $102.0 million in Q1 2025 and troughed at $73.8 million in Q4 2021.
  • The 5-year median for Current Deferred Revenue is $83.9 million (2023), against an average of $85.2 million.
  • The largest YoY upside for Current Deferred Revenue was 22.14% in 2021 against a maximum downside of 9.07% in 2021.
  • A 5-year view of Current Deferred Revenue shows it stood at $73.8 million in 2021, then grew by 7.66% to $79.5 million in 2022, then grew by 5.23% to $83.6 million in 2023, then increased by 0.72% to $84.2 million in 2024, then increased by 4.97% to $88.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Current Deferred Revenue are $88.4 million (Q4 2025), $85.7 million (Q3 2025), and $88.4 million (Q2 2025).